Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY   US1101221083

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Bristol Myers Squibb : Assigned Patent

07/25/2014 | 07:18am US/Eastern

By Targeted News Service

ALEXANDRIA, Va., July 25 -- Bristol-Myers Squibb, Princeton, New Jersey, has been assigned a patent (8,785,398) developed by four co-inventors for the "methods of treatment using CTLA4 mutant molecules." The co-inventors are Robert James Peach, San Diego, Joseph Naemura, Bellevue, Washington, Peter S. Linsley, Seattle, and Jurgen Bajorath, Bonn, Germany.

The patent application was filed on Oct. 20, 2011 (13/277,425). The full-text of the patent can be found at,85,398.PN.&OS=PN/87,85,398&RS=PN/87,85,398

Written by Sudarshan Harpal; edited by Jaya Anand.


(c) 2014 Targeted News Service

React to this article
07:05aDJEli Lilly Sales Hit by Patent Expirations, Currency
01/29 BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Approves Bristol-Myers ..
01/29 BRISTOL MYERS SQUIBB : Celldex Therapeutics and Bristol Myers-Squibb Announce In..
01/28 BRISTOL MYERS SQUIBB : Findings on Pharmaceutical and Biomedical Analysis Detail..
01/28 Roche falls as dividend, earnings disappoint investors
01/28 Otsuka announces 2014 fourth quarter U.S. net sales figures of ABILIFY
01/27 U.S. multinationals hit hard by strong dollar, to bleed further into 2015
01/27DJBristol-Myers Sales Boosted by Cancer Drugs -- Update
01/27 BRISTOL MYERS SQUIBB : Results of Operations and Financial Condition, Financial ..
01/27 BRISTOL MYERS SQUIBB : Pension charge, lower sales slash Bristol-Myers' Q4 profi..
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes